References

  1. Tham Yl, Sexton K, Weiss H et al. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxanes. Am J Clin Oncol. 2007;30(2):126-32. PubMed | Google Scholar

  2. Goodwin PJ, Ennis M, Pritchard KI et al. Risk of Menopause during the first year after breast cancer diagnosis. J clin Oncol. 1999; 17(8): 2365-2370. PubMed | Google Scholar

  3. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007;110 (10): 2222-9 124. PubMed | Google Scholar

  4. Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients; The International Breast Cancer Study Group. Ann Oncol. 1990;1(3):183-8. PubMed | Google Scholar

  5. Amir E, Freedman O, Allen L et al. Defining ovarian failure in amenorrheic young breast cancer patients. Breast. 2010; 19(6): 545-8. PubMed | Google Scholar

  6. Berlière M, Dalenc F, Malingret N et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer. 2008; 8: 56. PubMed | Google Scholar

  7. Reh A, Oktem O, Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril. 2008; 90(5):1635-9. PubMed | Google Scholar

  8. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996; 14(5):1718-29. PubMed | Google Scholar

  9. Martin M, Pienkowski T, Mackey J et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005; 352(22):2302-13. PubMed | Google Scholar

  10. Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006; 21(10):2583-92. PubMed | Google Scholar

  11. Halle CF, Moore MD, Joseph M et al. Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: an international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). J Clin Oncol. 2014; 32-512/mai/2016 15:13. PubMed | Google Scholar

  12. Conséquences des traitements des cancers et préservation de la fertilité, INCa et Agence de la biomédecine, 19 février 2013 ; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications. Visté le 18 janvier 2016. Google Scholar